Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell

Area of Science:

• Biochemistry
• Cardiovascular Biology
• Hematology

Background:

• Oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidant defenses, underlies numerous disorders, including hypercholesterolemia.
• Platelets are crucial in arterial thrombosis, with increased ROS production and impaired neutralization contributing to thrombotic processes.

Purpose of the Study:

• To review the role of oxidative stress in platelet hyperreactivity associated with hypercholesterolemia.
• To explore the link between lipid-lowering therapies and improved platelet function via redox balance mechanisms.

Main Methods:

• Literature review focusing on oxidative stress, platelet function, hypercholesterolemia, and lipid-lowering agents.
• Analysis of mechanisms involving oxidized LDL (oxLDL), scavenger receptors (e.g., CD36), signaling pathways (SFK, MAPK, NADPH oxidase), and intracellular redox balance.

Main Results:

• Hypercholesterolemia promotes platelet hyperreactivity through oxLDL-platelet interactions and oxidative stress.
• Activated platelets can exacerbate oxLDL generation, propagating further platelet activation and thrombus formation.
• Lipid-lowering therapies, including statins and PCSK9 inhibitors, exert beneficial effects on platelet function beyond LDL-C reduction, modulating redox balance.

Conclusions:

• Oxidative stress is a key mechanism linking hypercholesterolemia to platelet hyperreactivity and thrombogenesis.
• The pleiotropic effects of lipid-lowering agents on platelet function are significantly mediated by their impact on intracellular redox balance.